162 related articles for article (PubMed ID: 34621014)
1. Association between polygenic risk for Alzheimer's disease, brain structure and cognitive abilities in UK Biobank.
Tank R; Ward J; Flegal KE; Smith DJ; Bailey MES; Cavanagh J; Lyall DM
Neuropsychopharmacology; 2022 Jan; 47(2):564-569. PubMed ID: 34621014
[TBL] [Abstract][Full Text] [Related]
2. Investigating the synergistic effects of hormone replacement therapy, apolipoprotein E and age on brain health in the UK Biobank.
Ambikairajah A; Khondoker M; Morris E; de Lange AG; Saleh RNM; Minihane AM; Hornberger M
Hum Brain Mapp; 2024 Feb; 45(2):e26612. PubMed ID: 38339898
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer disease genetic risk factor APOE e4 and cognitive abilities in 111,739 UK Biobank participants.
Lyall DM; Ward J; Ritchie SJ; Davies G; Cullen B; Celis C; Bailey ME; Anderson J; Evans J; Mckay DF; Mcintosh AM; Sattar N; Smith DJ; Deary IJ; Pell JP
Age Ageing; 2016 Jul; 45(4):511-7. PubMed ID: 27103599
[TBL] [Abstract][Full Text] [Related]
4. Association between APOE e4 and white matter hyperintensity volume, but not total brain volume or white matter integrity.
Lyall DM; Cox SR; Lyall LM; Celis-Morales C; Cullen B; Mackay DF; Ward J; Strawbridge RJ; McIntosh AM; Sattar N; Smith DJ; Cavanagh J; Deary IJ; Pell JP
Brain Imaging Behav; 2020 Oct; 14(5):1468-1476. PubMed ID: 30903549
[TBL] [Abstract][Full Text] [Related]
5. Testing for associations between HbA1c levels, polygenic risk and brain health in UK Biobank (N = 39 283).
Ranglani S; Ward J; Sattar N; Strawbridge RJ; Lyall DM
Diabetes Obes Metab; 2023 Nov; 25(11):3136-3143. PubMed ID: 37435691
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E ε4 Modulates Cognitive Profiles, Hippocampal Volume, and Resting-State Functional Connectivity in Alzheimer's Disease.
Wang X; Wang J; He Y; Li H; Yuan H; Evans A; Yu X; He Y; Wang H
J Alzheimers Dis; 2015; 45(3):781-95. PubMed ID: 25624419
[TBL] [Abstract][Full Text] [Related]
7. Genetic influence of apolipoprotein E4 genotype on hippocampal morphometry: An N = 725 surface-based Alzheimer's disease neuroimaging initiative study.
Shi J; Leporé N; Gutman BA; Thompson PM; Baxter LC; Caselli RJ; Wang Y;
Hum Brain Mapp; 2014 Aug; 35(8):3903-18. PubMed ID: 24453132
[TBL] [Abstract][Full Text] [Related]
8. Assessing for interaction between
Lyall DM; Celis-Morales C; Lyall LM; Graham C; Graham N; Mackay DF; Strawbridge RJ; Ward J; Gill JMR; Sattar N; Cavanagh J; Smith DJ; Pell JP
Neurology; 2019 Jun; 92(23):e2691-e2698. PubMed ID: 31028125
[TBL] [Abstract][Full Text] [Related]
9. Association of SBP and BMI with cognitive and structural brain phenotypes in UK Biobank.
Ferguson AC; Tank R; Lyall LM; Ward J; Welsh P; Celis-Morales C; McQueenie R; Strawbridge RJ; Mackay DF; Pell JP; Smith DJ; Sattar N; Cavanagh J; Lyall DM
J Hypertens; 2020 Dec; 38(12):2482-2489. PubMed ID: 32665523
[TBL] [Abstract][Full Text] [Related]
10. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D Levels, APOE Allele, and MRI Volumetry Assessed by NeuroQuant in Norwegian Adults with Cognitive Symptoms.
Soares JZ; Pettersen R; Benth JŠ; Persson K; Strobel C; Selbæk G; Bogdanovic N
J Alzheimers Dis; 2021; 79(1):311-321. PubMed ID: 33252081
[TBL] [Abstract][Full Text] [Related]
12. Dissociable influences of
Ge T; Sabuncu MR; Smoller JW; Sperling RA; Mormino EC;
Neurology; 2018 May; 90(18):e1605-e1612. PubMed ID: 29592889
[TBL] [Abstract][Full Text] [Related]
13. Testing for Interactions Between APOE and Klotho Genotypes on Cognitive, Dementia, and Brain Imaging Metrics in UK Biobank.
Tank R; Ward J; Celis-Morales C; Smith DJ; Flegal KE; Lyall DM
J Alzheimers Dis; 2021; 83(1):51-55. PubMed ID: 34219715
[TBL] [Abstract][Full Text] [Related]
14. APOEɛ4 Gene Dose and Sex Effects on Alzheimer's Disease MRI Biomarkers in Older Adults with Mild Cognitive Impairment.
Hobel Z; Isenberg AL; Raghupathy D; Mack W; Pa J;
J Alzheimers Dis; 2019; 71(2):647-658. PubMed ID: 31424388
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's disease susceptibility genes APOE and TOMM40, and hippocampal volumes in the Lothian birth cohort 1936.
Lyall DM; Royle NA; Harris SE; Bastin ME; Maniega SM; Murray C; Lutz MW; Saunders AM; Roses AD; del Valdés Hernández MC; Starr JM; Porteous DJ; Wardlaw JM; Deary IJ
PLoS One; 2013; 8(11):e80513. PubMed ID: 24260406
[TBL] [Abstract][Full Text] [Related]
16. Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease.
Vemuri P; Wiste HJ; Weigand SD; Knopman DS; Shaw LM; Trojanowski JQ; Aisen PS; Weiner M; Petersen RC; Jack CR;
Ann Neurol; 2010 Mar; 67(3):308-16. PubMed ID: 20373342
[TBL] [Abstract][Full Text] [Related]
17. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW;
Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191
[TBL] [Abstract][Full Text] [Related]
18. The Association between Polygenic Hazard and Markers of Alzheimer's Disease Following Stratification for APOE Genotype.
De Marco M; Manca R; Kirby J; Hautbergue GM; Blackburn DJ; Wharton SB; Venneri A; Alzheimer's Disease Neuroimaging Initiative
Curr Alzheimer Res; 2020; 17(7):667-679. PubMed ID: 33023447
[TBL] [Abstract][Full Text] [Related]
19. Definition of Late Onset Alzheimer's Disease and Anticipation Effect of Genome-Wide Significant Risk Variants: Pilot Study of the APOE e4 Allele.
De Luca V; Spalletta G; Souza RP; Graff A; Bastos-Rodrigues L; Camargos Bicalho MA
Neuropsychobiology; 2019; 77(1):8-12. PubMed ID: 30110694
[TBL] [Abstract][Full Text] [Related]
20. APOE-ε4 risk variant for Alzheimer's disease modifies the association between cognitive performance and cerebral morphology in healthy middle-aged individuals.
Cacciaglia R; Molinuevo JL; Falcón C; Sánchez-Benavides G; Gramunt N; Brugulat-Serrat A; Esteller M; Morán S; Fauria K; Gispert JD;
Neuroimage Clin; 2019; 23():101818. PubMed ID: 30991302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
